*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Design And Evaluation Of Medicated Dermal Patches Of Proton Pump Inhibitor-Esomeprazole

Author: M.R.SHIVALINGAM , ARUL BALASUBRAMANIAN, KOTHAI RAMALINGAM
Abstract: Transdermal Drug Delivery System (TDDS), an innovative technique; releases the drug via the skin into systemic circulation at a predetermined manner at a controlled rate to sustain the release and to improve the safety and therapeutic efficacy of the drug for better patient compliance. An attempt was made in the present study to formulate an alternative dosage form as transdermal patches for Proton pump inhibitor (PPI) Esomeprazole which exists as a conventional and parenteral formulation for peptic ulcer treatment. To indicate that the drug is compatible with the formulation components, Drug-Excipient compatibility studies were performed using FT-IR. Transdermal patches of Esomeprazolewere prepared by the solvent evaporation method in which HPMC with PVP and HPMC with Eudragit L100 polymers were used in different ratios. All the formulated patches were evaluated for various parameters such as thickness, folding endurance, percentage moisture content, weight uniformity, swelling index, percentage moisture content, moisture uptake, water vapour transmission rate, and surface pH. All the formulated patches in this study satisfy characteristics related to integrity, flexibility, dispersion of drugs, and other quality control parameters. In vitro release studies of transdermal patches of ESMshows maximum availability of the drug in the systemic circulation (93.14 and 92.12 %), which in turn shows maximum bioavailability.
Keyword: Peptic ulcer; Transdermal Patch; Solvent evaporation method; Prolonged Release.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.418
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free